Serviços Personalizados
Journal
Artigo
Links relacionados
Compartilhar
Revista Médica del Uruguay
versão On-line ISSN 1688-0390
Resumo
TEJERA, Darwin et al. Complicaciones y mortalidad en esofagectomía por cáncer en unidades de medicina intensiva. Rev. Méd. Urug. [online]. 2015, vol.31, n.3, pp.155-164. ISSN 1688-0390.
Abstract Introduction: esophagectomy is still the most widely used treatment for esophageal cancer. Objectives: to describe frequency of complications and mortality after esophagectomy to treat complications and mortality of esophagectomy for esophageal cancer. Method: retrospective, multi-center study between 2001 and 2011. The study included patients who underwent programmed esophagectomy to treat esophageal cancer during their stay in intensive care units. Results: 224 patients were included in the study, 72% were men, average age was 61 years old and ± 11 standard deviation. Surgical approach was transhiatal in 69.7% of cases and transthoracic in 30.3%. Morbility was 70.5% and mortality 13.8%. Complications identified were respiratory 50.8%, infectious 51.3%, cardiovascular 27.6% and surgical 23.6%. Acute respiratory distress syndrome (p = 0.03), anostomotic leaks (p = 0.001), severe sepsis (p = 0.001), mediastinitis (p = 0.02) and acute renal injury (p = 0.01) were associated to mortality. Severe sepsis was the main cause of death with mediastinal or respiratory focus, or both. In the multivariate analysis, failure of extubation (OR 3.9; IC 95% 1.02-15.30; p = 0.03), intraoperative transfusion (OR 5.6; IC 95% 2.07-15.60; p = 0.001) and severe sepsis (OR 29; IC 95% 1.72-21.30; p = 0.001) were the variables independently associated. Conclusions: morbimortality rates are high in esophagectomy. The most common complications were respiratory and infectious. Severe sepsis was the main cause of death. Failure to extubate, preoperative radiotherapy, intraoperative transfusion and severe sepsis were associated to greater mortality rates.
Palavras-chave : ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; POSTOPERATIVE COMPLICATIONS; MORTALITY.